Co-medication with anti-emetics may reduce the incidence of MTX-induced nausea and behavioral therapies may reduce the occurrence of anticipatory nausea, Sonja Falvey, MD, of the University of Alabama at Birmingham, and colleagues reported in a review published in Pediatric Rheumatology.
